Simeng Wen

Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100

Ferroptosis: molecular mechanisms and health implications

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?

The molecular machinery of regulated cell death

Inflammation and tumor progression: signaling pathways and targeted intervention

Pyroptosis: mechanisms and diseases

Luteoloside Suppresses Proliferation and Metastasis of Hepatocellular Carcinoma Cells by Inhibition of NLRP3 Inflammasome

Broadening horizons: the role of ferroptosis in cancer

Metabolic exchanges within tumor microenvironment

Enzalutamide for the Treatment of Prostate Cancer: Results and Implications of the AFFIRM Trial

Enzalutamide: A Novel Antiandrogen for Patients with Castrate-Resistant Prostate Cancer

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Nutraceutical or Pharmacological Potential of Moringa oleifera Lam.

Copper induces cell death by targeting lipoylated TCA cycle proteins

Moringa oleifera Lam: Targeting Chemoprevention

Cancer treatment and survivorship statistics, 2014

Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death

Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling

Androgen receptor enhances entosis, a non‐apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells

MDV3100 effects on androgen receptor (AR) signaling and bone marrow testosterone concentration modulation: Apreliminary report.